`

Virscio

Biotechnology Research

Specialities :
Toxicology study
Safety pharmacology
Preclinical study
Glp / non-glp study
Ind-enabling

+3

revenue-icon Revenue
11M - 100M
funding-icon Total Funding
--
size-icon Size
51 - 200

Frequently Asked Questions About Virscio

What does Virscio do?+

Virscio is a specialty translational research organization developing and providing innovative in vivo disease modeling and related preclinical research and development services to meet the preclinical, translational, and regulatory research needs of the pharmaceutical and life sciences industry. We specialize in the fields of ophthalmology, central nervous system, cardiovascular and metabolic related disease and disorders, and have advanced discovery and development programs for a wide range of sponsors, collaborators, and partners around the world, ranging from large pharmaceutical companies and venture-backed biotechnology companies to academic teams seeking to apply the most cutting edge research and development strategies in the most...

What are Virscio's specialties? +

Toxicology study,safety pharmacology,preclinical study,glp / non-glp study,ind-enabling,research support services,drug development,and pharmaceutical research

What is Virscio's industry? +

Virscio operates in the Biotechnology research industry.

What is Virscio's revenue? +

Virscio's revenue is 11m - 100m

What is Virscio's company size? +

Virscio has 51 - 200 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.